According to the World Health Organization (WHO), the deadly Ebola outbreak in West Africa could infect more than 20,000 people before it is brought under control.
The WHO said the number of cases could already be four times higher than the 3,000 currently registered.
It also called on airlines to resume “vital” flights across the region, saying travel bans were threatening efforts to beat the epidemic.
So far, 1,552 people in Liberia, Sierra Leone, Guinea and Nigeria have died.
Announcing a WHO action plan to deal with the outbreak, Bruce Aylward said “the actual number of cases may be 2-4 fold higher than that currently reported” in some areas.
The WHO assistant director-general said the possibility of 20,000 cases “is a scale that I think has not ever been anticipated in terms of an Ebola outbreak”.
“That’s not saying we expect 20,000… but we have got to have a system in place that we can deal with robust numbers,” he added.
The WHO plan calls for $489 million to be spent over the next nine months and requires 750 international workers and 12,000 national workers across West Africa.
On August 28, Nigeria confirmed its first Ebola death outside Lagos, with an infected doctor in the oil hub of Port Harcourt dying from the disease.
Operations have not yet been affected in Africa’s biggest oil producer, but a spokesman for Shell’s Nigerian subsidiary said they were “monitoring the Ebola outbreak very closely”.
Health ministers from across West Africa are meeting in Ghana at an extraordinary meeting of the Economic Community of West African States (ECOWAS) to discuss how to prevent the virus from spreading further.
Officials at the ECOWAS session backed the WHO’s call for flight bans to be ended and called for states to reopen their borders to make it easier for health workers to access affected areas.
Earlier Bruce Aylward insisted bans on travel and trade would not stop the spread of Ebola, saying they were “more likely to compromise the ability to respond”.
Despite rumors to the contrary, the Ebola virus is not airborne and is spread by humans coming into contact with bodily fluids, such as sweat and blood, from those infected with virus.
Medical agencies in West Africa are struggling to cope with an increasing number of cases and growing hostility from communities in certain affected areas.
Efforts to prevent the virus spreading are unlikely to see any results given that most treatment centers are already operating at full capacity.
Meanwhile, British medical charity Wellcome Trust and pharmaceuticals giant GlaxoSmithKline (GSK) said safety trials on an experimental Ebola vaccine are being fast-tracked.
GSK says it plans to build up a stockpile of up to 10,000 doses for emergency deployment if results from the trials, which could begin as soon as next month, are good.
[youtube Os3mtqbG2u4 650]